GB1413070A - Process for the production of - norfenfluramine and - fenfluramine and salts thereof - Google Patents
Process for the production of - norfenfluramine and - fenfluramine and salts thereofInfo
- Publication number
- GB1413070A GB1413070A GB3592373A GB3592373A GB1413070A GB 1413070 A GB1413070 A GB 1413070A GB 3592373 A GB3592373 A GB 3592373A GB 3592373 A GB3592373 A GB 3592373A GB 1413070 A GB1413070 A GB 1413070A
- Authority
- GB
- United Kingdom
- Prior art keywords
- norfenfluramine
- prepared
- group
- salt
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/44—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers
- C07C209/52—Preparation of compounds containing amino groups bound to a carbon skeleton by reduction of carboxylic acids or esters thereof in presence of ammonia or amines, or by reduction of nitriles, carboxylic acid amides, imines or imino-ethers by reduction of imines or imino-ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1413070 (-)-Norfenfluramine BEECHAM GROUP Ltd 18 July 1974 [27 July 1973] 35923/73 Heading C2C (-)-Norfenfluramine or a salt thereof may be prepared by hydrogenating the novel compound of Formula (I) or a salt thereof: where R is a phenyl group, optionally substituted in the meta- or para-positions by a non- reactive group that does not interfere with the hydrogenation, the carbon atom marked with one asterisk has the same configuration as (-)-norfenfluramine and the carbon atom marked with two asterisks has the configuration found in (+ )-a-methylbenzylamine. The compound of Formula (I) may be prepared by reducing a compound of Formula II or a salt thereof: which may itself be prepared by reacting l-(mtrifluoromethylphenyl)propan-2-one with (+ )- α-methylbenzylamine. (-)-Fenfluramine may be prepared by the acetylation of (-)-norfenfluramine in conventional manner followed by reduction of the acetyl group to an ethyl group.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3592373A GB1413070A (en) | 1973-07-27 | 1973-07-27 | Process for the production of - norfenfluramine and - fenfluramine and salts thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3592373A GB1413070A (en) | 1973-07-27 | 1973-07-27 | Process for the production of - norfenfluramine and - fenfluramine and salts thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1413070A true GB1413070A (en) | 1975-11-05 |
Family
ID=10383048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3592373A Expired GB1413070A (en) | 1973-07-27 | 1973-07-27 | Process for the production of - norfenfluramine and - fenfluramine and salts thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1413070A (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0875498A2 (en) * | 1997-04-28 | 1998-11-04 | Alfa Chemicals Italiana S.r.l. | Process for the production of the isomers (R) and (S)-Alpha-methyl-3-(trifluoromethyl)benzeneethanamine |
WO2014177676A1 (en) | 2013-05-03 | 2014-11-06 | Katholieke Universiteit Leuven | Fenfluramine for use in the treatment of dravet syndrome |
WO2018206924A1 (en) | 2017-05-09 | 2018-11-15 | Zogenix International Limited | Methods of treating doose syndrome using fenfluramine |
WO2019067413A1 (en) | 2017-09-26 | 2019-04-04 | Zogenix International Limited | Use of fenfluramine formulation in reducing number and frequencies of convulsive seizures in patient populations |
WO2019067405A2 (en) | 2017-09-26 | 2019-04-04 | Zogenix International Limited | Ketogenic diet compatible fenfluramine formulation |
WO2019067419A1 (en) | 2017-09-26 | 2019-04-04 | Zogenix International Limited | Improvement in cognitive function with fenfluramine |
WO2020014075A1 (en) | 2018-07-10 | 2020-01-16 | Zogenix International Limited | Fenfluramine for use for treating epilepsy or epileptic encephalopathy in patients without pulmonary hypertension |
WO2020105005A1 (en) | 2018-11-19 | 2020-05-28 | Zogenix International Limited | Methods of treating rett syndrome using fenfluramine |
WO2021053389A1 (en) | 2019-09-17 | 2021-03-25 | Zogenix International Limited | Methods of treating epileptic patients with fenfluramine |
WO2021156437A1 (en) | 2020-02-05 | 2021-08-12 | Zogenix International Limited | Fenfluramine for use in treating patients with lennox-gastaut syndrome |
WO2022013425A1 (en) | 2020-07-17 | 2022-01-20 | Zogenix International Limited | Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (sars-cov-2) |
US11634377B2 (en) | 2015-12-22 | 2023-04-25 | Zogenix International Limited | Fenfluramine compositions and methods of preparing the same |
US11673852B2 (en) | 2015-12-22 | 2023-06-13 | Zogenix International Limited | Metabolism resistant fenfluramine analogs and methods of using the same |
US11759440B2 (en) | 2016-08-24 | 2023-09-19 | Zogenix International Limited | Formulation for inhibiting formation of 5-HT2B agonists and methods of using same |
-
1973
- 1973-07-27 GB GB3592373A patent/GB1413070A/en not_active Expired
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0875498A3 (en) * | 1997-04-28 | 2000-07-26 | Alfa Chemicals Italiana S.r.l. | Process for the production of the isomers (R) and (S)-Alpha-methyl-3-(trifluoromethyl)benzeneethanamine |
EP0875498A2 (en) * | 1997-04-28 | 1998-11-04 | Alfa Chemicals Italiana S.r.l. | Process for the production of the isomers (R) and (S)-Alpha-methyl-3-(trifluoromethyl)benzeneethanamine |
WO2014177676A1 (en) | 2013-05-03 | 2014-11-06 | Katholieke Universiteit Leuven | Fenfluramine for use in the treatment of dravet syndrome |
EP3329909A1 (en) | 2013-05-03 | 2018-06-06 | Katholieke Universiteit Leuven KU Leuven Research & Development | Fenfluramine for use in the treatment of dravet syndrome |
US11634377B2 (en) | 2015-12-22 | 2023-04-25 | Zogenix International Limited | Fenfluramine compositions and methods of preparing the same |
US11673852B2 (en) | 2015-12-22 | 2023-06-13 | Zogenix International Limited | Metabolism resistant fenfluramine analogs and methods of using the same |
US11786487B2 (en) | 2016-08-24 | 2023-10-17 | Zogenix International Limited | Formulation for inhibiting formation of 5-HT2B agonists and methods of using same |
US11759440B2 (en) | 2016-08-24 | 2023-09-19 | Zogenix International Limited | Formulation for inhibiting formation of 5-HT2B agonists and methods of using same |
WO2018206924A1 (en) | 2017-05-09 | 2018-11-15 | Zogenix International Limited | Methods of treating doose syndrome using fenfluramine |
WO2019067413A1 (en) | 2017-09-26 | 2019-04-04 | Zogenix International Limited | Use of fenfluramine formulation in reducing number and frequencies of convulsive seizures in patient populations |
WO2019067405A2 (en) | 2017-09-26 | 2019-04-04 | Zogenix International Limited | Ketogenic diet compatible fenfluramine formulation |
WO2019067419A1 (en) | 2017-09-26 | 2019-04-04 | Zogenix International Limited | Improvement in cognitive function with fenfluramine |
WO2020014075A1 (en) | 2018-07-10 | 2020-01-16 | Zogenix International Limited | Fenfluramine for use for treating epilepsy or epileptic encephalopathy in patients without pulmonary hypertension |
WO2020105005A1 (en) | 2018-11-19 | 2020-05-28 | Zogenix International Limited | Methods of treating rett syndrome using fenfluramine |
WO2021053389A1 (en) | 2019-09-17 | 2021-03-25 | Zogenix International Limited | Methods of treating epileptic patients with fenfluramine |
WO2021156437A1 (en) | 2020-02-05 | 2021-08-12 | Zogenix International Limited | Fenfluramine for use in treating patients with lennox-gastaut syndrome |
US11612574B2 (en) | 2020-07-17 | 2023-03-28 | Zogenix International Limited | Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
WO2022013425A1 (en) | 2020-07-17 | 2022-01-20 | Zogenix International Limited | Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (sars-cov-2) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1413070A (en) | Process for the production of - norfenfluramine and - fenfluramine and salts thereof | |
GB1413078A (en) | Process for the production of plus-norfenfluramine and plus-fenfluramine and salts thereof | |
GB1432576A (en) | Substituted phenylacetic acids | |
GB1425532A (en) | Cyclic mercaptals and a process for the manufacture thereof | |
GB1489779A (en) | Process of preparing a stable composition containing a compound of the prostaglandin e group | |
GB1129029A (en) | Tricyclic ethylamine derivatives | |
GB1448316A (en) | Racemization of optically active 2,2-dimethyl-3,1,-alkenyl- cyclopropane-1-carboxylic acids | |
GB1386150A (en) | 6-acylaminophenyl-4,5-dihydropyridazones | |
GB1428341A (en) | Process for preparing 4,5-diphenyl-oxazol-2-one | |
GB1453906A (en) | 3-deoxyglucose derivatives | |
GB1454850A (en) | Process for the enzymatic isomerisation of glucose to levulose | |
GB1353713A (en) | Process for the preparation of squaric acid | |
GB1444565A (en) | Process for conversion of alkyl transchrysantemates in admixture with alkyl cis-chrysanthemates to the corresponding acid | |
GB1339053A (en) | Method for the preparation of aromatic a-amino acids and intermediates therefor | |
GB1414452A (en) | Process for the manufacture of cyclohexadienes | |
GB562267A (en) | Process for the manufacture of a crystallised, non-hygroscopic calcium salt of d-pantothenic acid | |
GB1515614A (en) | Preparation of m-benzoylhydratropic acid and an intermediate therefor | |
GB1329382A (en) | Aromatic diamines and a process for the production thereof | |
GB1311703A (en) | Carbamates their manufacture and use as pesticides | |
GB1446701A (en) | Vincamine 2-ketoglutarate and process for the production thereof | |
GB1479731A (en) | Process for the production of crystals of monosodium glutamate pentahydrate | |
GB1310382A (en) | Process for the preparation of glucofuranosides | |
ES374798A1 (en) | Enzymatic resolution of racemic (cis-1,2-epoxypropyl) phosphonic acid compounds | |
GB1259929A (en) | A process of preparing novel n-alpha-acetyl-2-o-methyltyrosine-oxytocin possessing inhibitory properties | |
GB1383522A (en) | 2-methyl-6-chloropyridines and salts thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
414F | Notice of opposition given (sect. 14/1949) | ||
414C | Case decided by the comptroller ** grants refused (sect. 14/1949) | ||
CSNS | Application of which complete specification have been accepted and published, but patent is not sealed |